Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Ophthalmology

Genetics and Biological Roots of PPCD

At a Glance

Posterior Polymorphous Corneal Dystrophy (PPCD) is an inherited eye condition caused by genetic changes that make corneal pump cells act like skin cells. It is autosomal dominant, meaning a parent with the gene has a 50% chance of passing it to their child.

At its core, Posterior Polymorphous Corneal Dystrophy (PPCD) is a condition where the instructions for certain eye cells get mixed up. To understand why this happens, it helps to look at the “biological switch” that controls how your eye cells behave and why PPCD can look different from other eye conditions.

The Biological Switch: What is Metaplasia?

Your cornea depends on a single layer of cells on the back surface called the endothelium. In a healthy eye, these cells are specialized “pumps.” In PPCD, a process called metaplasia occurs—the endothelial cells inappropriately transform and start acting like surface skin cells (epithelial cells) [1][2].

This happens because of a breakdown in a genetic “regulatory axis” involving key genes: ZEB1, OVOL2, GRHL2, and historically COL8A2 [3][4].

  • ZEB1: Think of this as a guardian that keeps cells in their correct “pump” state [5].
  • OVOL2 and GRHL2: These genes typically act as “epithelial gatekeepers.” If they become overactive or if ZEB1 stops working, the gate opens, and the pump cells transform into skin-like cells [6][7][3].
  • COL8A2: Alterations in this gene have been linked specifically to PPCD2 [4].

How PPCD is Inherited (And the Risk to Children)

PPCD is typically an Autosomal Dominant condition. This means you only need one copy of the changed gene from one parent to have the condition.

Because it is dominant, a person with PPCD has a 50% chance of passing the gene to each child. It is highly recommended that the children of a diagnosed parent receive their first screening eye exam early in childhood, even if they show no symptoms. However, understanding the family tree can sometimes be confusing due to a few factors:

  • Incomplete Penetrance: A person can carry the PPCD gene but show absolutely no symptoms or physical signs of the disease [8][9].
  • Variable Expressivity: Even within the same family, one person may have very mild changes while another may need a transplant [8].
  • De Novo Mutations: Sometimes, the genetic change happens for the first time in the patient (“de novo”), meaning neither parent carries the gene.

Telling the Difference: PPCD Look-Alikes

Because several conditions can cause the cornea to look “cloudy,” doctors must rule out other “look-alikes.”

Condition Primary Gene Key Differences from PPCD
PPCD ZEB1, OVOL2, GRHL2, COL8A2 Often stable; cells look like “skin” on the back of the cornea [4][2].
Fuchs Dystrophy (FECD) TCF4 Usually appears in older adults (50+); characterized by “guttata” (tiny drops) on the cornea [10][11].
CHED SLC4A11 Recessive (needs two gene copies); present at birth with severe, milky-white swelling in both eyes [2][12].
ICE Syndrome None (Not inherited) Usually affects only one eye; involves significant changes to the iris (the colored part of the eye) [13].

Getting the correct diagnosis is vital because conditions like CHED are present at birth and require much more aggressive intervention than the typical case of PPCD [12][14].

Common questions in this guide

Is PPCD hereditary and can I pass it to my children?
Yes, PPCD is typically an autosomal dominant condition. This means you only need one copy of the changed gene to have the condition, and you have a 50% chance of passing the gene to each of your children.
If I have the gene for PPCD but no symptoms, will my children get it?
Yes. Because of a genetic trait called incomplete penetrance, you can carry the PPCD gene without ever showing symptoms. Even without symptoms, you still have a 50% chance of passing the gene to your child, and they may develop visible signs of the condition.
What causes the cells in my eye to change in PPCD?
In PPCD, a process called metaplasia occurs due to a breakdown in genes like ZEB1, OVOL2, or GRHL2. This genetic switch causes the cells that normally pump fluid out of your cornea to inappropriately transform into surface skin cells.
How do doctors know I have PPCD and not Fuchs Dystrophy?
While both conditions affect the cornea, Fuchs Dystrophy usually appears in older adults and features tiny drops called guttata on the cornea. PPCD is caused by different genes and causes the cells on the back of the cornea to look more like a layer of skin.
Why is it important to know my specific genetic subtype for PPCD?
Identifying your specific genetic subtype, such as a change in the ZEB1 gene, can confirm the diagnosis and help differentiate PPCD from conditions that look similar, like ICE syndrome. It also helps your doctor determine the best monitoring schedule for you and your family.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since PPCD has 'incomplete penetrance,' if I have the gene but no symptoms, can I still pass it to my child?
  2. 2.Does my child's mutation involve the ZEB1 gene, and if so, should we be concerned about other developmental issues?
  3. 3.How can we be certain this is PPCD and not Iridocorneal Endothelial (ICE) syndrome, especially if it only appears in one eye?
  4. 4.Which genetic subtype (PPCD1, PPCD2, PPCD3, or PPCD4) was identified, and does that change our monitoring schedule?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    [Imaging features of posterior polymorphous corneal dystrophy observed by in vivo confocal microscopy].

    Gu SF, Peng RM, Xiao GG, Hong J

    [Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2022; (58(2)):103-111 doi:10.3760/cma.j.cn112142-20210228-00099.

    PMID: 35144350
  2. 2

    Diseases of the corneal endothelium.

    Jeang LJ, Margo CE, Espana EM

    Experimental eye research 2021; (205()):108495 doi:10.1016/j.exer.2021.108495.

    PMID: 33596440
  3. 3

    Alterations in GRHL2-OVOL2-ZEB1 axis and aberrant activation of Wnt signaling lead to altered gene transcription in posterior polymorphous corneal dystrophy.

    Chung DD, Zhang W, Jatavallabhula K, et al.

    Experimental eye research 2019; (188()):107696 doi:10.1016/j.exer.2019.107696.

    PMID: 31233731
  4. 4

    Posterior corneal vesicles are not associated with the genetic variants that cause posterior polymorphous corneal dystrophy.

    Liskova P, Hafford-Tear NJ, Skalicka P, et al.

    Acta ophthalmologica 2022; (100(7)):e1426-e1430 doi:10.1111/aos.15114.

    PMID: 35174971
  5. 5

    The Curious Case of ZEB1.

    Madany M, Thomas T, Edwards LA

    Discoveries (Craiova, Romania) 2018; (6(4)):e86 doi:10.15190/d.2018.7.

    PMID: 32309604
  6. 6

    OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.

    Murata M, Ito T, Tanaka Y, et al.

    Journal of clinical medicine 2020; (9(3)) doi:10.3390/jcm9030618.

    PMID: 32106476
  7. 7

    GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.

    Chung VY, Tan TZ, Tan M, et al.

    Scientific reports 2016; (6()):19943 doi:10.1038/srep19943.

    PMID: 26887977
  8. 8

    Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.

    Kingdom R, Wright CF

    Frontiers in genetics 2022; (13()):920390 doi:10.3389/fgene.2022.920390.

    PMID: 35983412
  9. 9

    Loss-of-function variants in ZEB1 cause dominant anomalies of the corpus callosum with favourable cognitive prognosis.

    Heide S, Argilli E, Valence S, et al.

    Journal of medical genetics 2024; (61(3)):244-249 doi:10.1136/jmg-2023-109293.

    PMID: 37857482
  10. 10

    [Fuchs endothelial corneal dystrophy and trinucleotide repeat expansion in TCF4--implications for diagnostics and therapy].

    Oziębło D, Szaflik JP, Ołdak M

    Klinika oczna 2015; (117(3)):200-3.

    PMID: 26999947
  11. 11

    Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy.

    Liu X, Zheng T, Zhao C, et al.

    Eye and vision (London, England) 2021; (8(1)):24 doi:10.1186/s40662-021-00246-2.

    PMID: 34130750
  12. 12

    Molecular Mechanisms of Fuchs and Congenital Hereditary Endothelial Corneal Dystrophies.

    Malhotra D, Casey JR

    Reviews of physiology, biochemistry and pharmacology 2020; (178()):41-81 doi:10.1007/112_2020_39.

    PMID: 32789790
  13. 13

    Posterior Polymorphous Corneal Dystrophy in a Patient with a Novel ZEB1 Gene Mutation.

    Fernández-Gutiérrez E, Fernández-Pérez P, Boto-De-Los-Bueis A, et al.

    International journal of molecular sciences 2022; (24(1)) doi:10.3390/ijms24010209.

    PMID: 36613650
  14. 14

    Updates on congenital hereditary endothelial dystrophy.

    Mehta N, Verma A, Achanta DS, et al.

    Taiwan journal of ophthalmology 2023; (13(4)):405-416 doi:10.4103/tjo.TJO-D-23-00135.

    PMID: 38249503

This page explains the genetic basis of PPCD for educational purposes only. Always consult a genetic counselor or ophthalmologist to understand your specific family risks and diagnostic results.

Get notified when new evidence is published on Posterior polymorphous corneal dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.